Why Lykos Therapeutics’ MDMA data had a bad trip | Drug Discovery News

Why Lykos Therapeutics’ MDMA data had a bad trip | Drug Discovery News: An FDA advisory panel voted against recommending the psychedelic MDMA for PTSD, puncturing excitement around the drug’s potential.